Trial Profile
An open trial with TNF [tumour necrosis factor] blockade with infliximab (Remicade), in patients with chronic inflammatory myopathies
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Myositis
- Focus Therapeutic Use
- 10 Apr 2007 New trial record.